DJIA 16,643.01 -11.76 -0.07%
NASDAQ 4,828.33 15.62 0.32%
S&P 500 1,988.87 1.21 0.06%
market minute promo

236.12 1.22 (0.52%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

VRX $236.12 0.52%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $232.73
Previous Close $234.90
Daily Range $232.04 - $236.36
52-Week Range $111.41 - $263.81
Market Cap $80.9B
P/E Ratio 96.67
Dividend (Yield) $0.00 (0.0%)
Volume 982,983
Average Daily Volume 1,980,756
Current FY EPS $2.96




Drug Makers

Valeant Pharmaceuticals (VRX) Description

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology. Website:

News & Commentary

The Berkshire Hathaway of Biotech Strikes Again

Valeant Pharmaceuticals adds to its growing portfolio of products with the purchase of Sprout Pharmaceuticals. Find out what's made Valeant such a great stock to own, and what investors should be monitoring going forward.

Acelity Files To Float, But Is It Secretly Seeking A Buyer?

Sequoia Fund Comments on Valeant Pt. II

Sequoia Fund Comments on Valeant Pt. II

This Week In Pharma: Keryx's Sluggish Drug Launch Vs. Excitement At Valeant And Palatin

Insider Trading Alert - VRX, WSTC And CPHD Traded By Insiders

Sucampo to Acquire R-Tech Ueno for About $278 Million

Sequoia Fund Comments on Valeant Pharmaceuticals

Glenn Greenberg Acquires Two New Stakes

Valeant Pharmaceuticals' (VRX) Charts Read Like a Textbook Bull

Exelixis' Cancer Drug Gets Breakthrough Therapy Status

See More VRX News...

VRX's Top Competitors

VRX $236.12 (0.52%)
Current stock: VRX
JNJ $95.17 (-1.09%)
Current stock: JNJ
NVS $98.35 (-0.29%)
Current stock: NVS
RHHBY $34.16 (-1.98%)
Current stock: RHHBY